BMC Psychiatry Volume 5
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
 Research articleExpression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depressionKirenjeet Ubhi and Jack Price  Institute of Psychiatry, Kings College London, Denmark Hill, London, UK author email corresponding author email
BMC Psychiatry 2005,
5:38doi:10.1186/1471-244X-5-38
|
|
| Published: |
24 October 2005 |
Abstract
Background
The POU-domain transcription factor Oct-6 has been reported to be differentially expressed between schizophrenic and control post-mortem brains. In this study, we attempted to replicate this finding and to discover whether Oct-6 was also dysregulated in bipolar disorder and major depression.
Methods
Oct-6 mRNA and protein expression were determined by in-situ hybridization and immunohistochemistry respectively in sections of post-mortem brain.
Results
We did not observe any differences in Oct-6 expression between any of the groups under study. Oct-6 mRNA and protein was identically expressed in the hippocampal and cortical regions of most specimens in all groups, including controls.
Conclusion
Oct-6 is, therefore, unlikely to be a specific marker for any psychological disorder; rather its expression in controls suggests that it is normally expressed in most adult brains. |